KAI1, A prostate metastasis suppressor: Prediction of solvated structure and interactions with binding partners; integrins, cadherins, and cell‐surface receptor proteins†
Tóm tắt
The solution structure of the transmembrane‐4 superfamily protein KAI1, a recently identified prostate cancer metastasis suppressor gene that encodes a 267–amino acid protein, was modeled. The structure of this four‐helical transmembrane protein was developed by defining and modeling sections individually. A complete three‐dimensional structure for the solvated protein was developed by combining the individually modeled sections. The four‐helix transmembrane bundle structure was predicted combining information from several methods including Fourier transform analysis of residue variability for helix orientation. The structure of the KAI1 large extracellular domain was modeled based on the solved crystal structure of the extracellular domain of another tetraspanin superfamily protein member, CD81 (hepatitis C virus envelope E2 glycoprotein receptor). This is a novel protein fold consisting of five alpha helices held together by two disulfide bonds for which the CD81 protein is the first solved representative. Molecular dynamics studies were performed to test stability and to relax the total model KAI1 structure's solution. The resulting KAI1 structural model should be a useful tool for predicting modes of self‐association and associations with other TM4SF proteins, integrins, cadherins, and other KAI1 binding partners. Mutations for probing the interactions of KAI1 with antibodies and with other binding partners are suggested. Published 2001 Wiley‐Liss, Inc.
Từ khóa
Tài liệu tham khảo
Dong JT, 1996, Down‐regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss, Cancer Res, 56, 4387
Ueda T, 1996, Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer, Am J Pathol, 149, 1435
Adachi M, 1996, Correlation of KAI1/CD82 gene expression with good prognosis in patients with non‐small cell lung cancer, Cancer Res, 56, 1751
Yu Y, 1997, Loss of KAI1 messenger RNA expression in both high‐grade and invasive human bladder cancers, Clin Cancer Res, 3, 1045
Huang CL, 1997, MRP‐1/CD9 and KAI1/CD82 expression in normal and various cancer tissues, Int J Oncol, 11, 1045
Guo A, 1996, KAI1 Expression in up‐regulated in early pancreatic cancer and decreased in the presence of metastases, Cancer Res, 56, 4876
Ono M, 1999, Motility inhibition and apoptosis are induced by metastasis‐suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation, Cancer Res, 59, 2335
Szollisi J, 1996, Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY, J Immunol, 157, 2939, 10.4049/jimmunol.157.7.2939
Lagaudriere‐Gesbert C, 1997, The tetraspanin protein CD82 associates with both free HLA Class I heavy chain and heterodimeric b2‐microglobulin complexes, J Immunol, 158, 2790, 10.4049/jimmunol.158.6.2790
Hammond C, 1998, The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA‐DR,‐DM, and ‐DO molecules, J Immunol, 161, 3282, 10.4049/jimmunol.161.7.3282
Mannion BA, 1996, Transmembrane‐4 superfamily proteins CD81 (TAPA‐1), CD82, CD63, and CD53 specifically associate with integrin α4β1 (CD49d/CD29), J Immunol, 157, 2039, 10.4049/jimmunol.157.5.2039
Afshari C, 1999, Interaction of the metastasis suppressing proteins KAI1 and E‐cadherin in epithelial cells, Proc Am Assoc Cancer Res, 40, 197
Lebel‐Binay S, 1995, CD82, member of the tetra‐span‐transmembrane protein family, is a costimulatory protein for T cell activation, J Immunol, 155, 101, 10.4049/jimmunol.155.1.101
Berdichevshi F, 1997, A novel link between integrins, transmembrane‐4 superfamily proteins (CD63 and CD81), and phosphatidylinositol 4‐kinase, J Biol Chem, 272, 2595, 10.1074/jbc.272.5.2595
Hoffman K, 1993, Tmbase — a database of membrane spanning protein segments, Biol Chem Hoppe‐Seyler, 374, 166
Taylor WR, 1995, Protein folds—a distance based approach, 283
Fauchere JL, 1983, Hydrophobic parameters of amino‐acid side chains from the partitioning of N‐acetyl amino acid amides, Eur J Med Chem, 18, 369
Donnelly D, 1993, Modeling α‐helical transmembrane domains: The calculation and use of substitution tables for lipid‐facing residues, Protein Sci, 2, 55, 10.1002/pro.5560020106
Geourjon C, 1995, Significant improvements in protein secondary structure prediction by prediction from multiple alignments, Comput Appl Biosci, 11, 681